← Leaderboards
Gordon S Huggins
Harvard University (Sch Of Public Hlth)
$5,517,028
Attributed
$8,119,073
Total exposure
8
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $778.7K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,119,073 · 8
By mechanism
R01$5,835,614 · 4
U10$1,651,400 · 1
K08$345,141 · 1
S10$286,918 · 2
Top collaborators
- Peter C Vanburen5 shared
- Lauren D. Black4 shared
- Philip W Hinds4 shared
- Howard H. Chen2 shared
Others in their field
Top investigators on “Programs”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,641,009,751
- Leonard Freedman · Leidos Biomedical Research, Inc.$994,984,644
- Lawrence Corey · Fred Hutchinson Cancer Center$730,186,538
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$609,313,548
Research focus
ProgramsTranscription FactorCell Growth RegulationCardiacResearch PersonnelHeart FailureCardiac MyocytesAffectTissuesInsightResponseHeartSerumFunctional DisorderHeart TransplantationMyocardialStagingStem CellsGenesEchocardiographyCell ProliferationAnimalsCellsMutation
Grant awards (27)
FHOD3 Regulation of Autophagy Pathway in Cardiomyopathy$778,738
R01 · FY2025 · HL · contact PI
FHOD3 Regulation of Autophagy Pathway in Cardiomyopathy$703,358
R01 · FY2024 · HL · contact PI
New England, New York and Quebec Regional Clinical Center$330,280
U10 · FY2018 · HL
New England, New York and Quebec Regional Clinical Center$330,280
U10 · FY2017 · HL
New England, New York and Quebec Regional Clinical Center$330,280
U10 · FY2016 · HL
Basic Mechanisms of Human Calcific Aortic Valve Disease$386,651
R01 · FY2015 · HL · contact PI
New England, New York and Quebec Regional Clinical Center$330,280
U10 · FY2015 · HL
Basic Mechanisms of Human Calcific Aortic Valve Disease$384,793
R01 · FY2014 · HL · contact PI
New England, New York and Quebec Regional Clinical Center$330,280
U10 · FY2014 · HL
Basic Mechanisms of Human Calcific Aortic Valve Disease$373,899
R01 · FY2013 · HL · contact PI
Basic Mechanisms of Human Calcific Aortic Valve Disease$407,602
R01 · FY2012 · HL · contact PI
Alcohol and Muscle Stem Cells$280,129
R01 · FY2009 · AA · contact PI
BioTrove Open Array Platform$127,980
S10 · FY2009 · RR · contact PI
Alcohol and Muscle Stem Cells$23,850
R01 · FY2009 · AA · contact PI
Alcohol and Muscle Stem Cells$280,129
R01 · FY2008 · AA · contact PI
Alcohol and Muscle Stem Cells$280,129
R01 · FY2007 · AA · contact PI
Applied Biosystems 7900HT Fast Real-Time PCR System$158,938
S10 · FY2007 · RR · contact PI
Alcohol and Muscle Stem Cells$288,495
R01 · FY2006 · AA · contact PI
Alcohol and Muscle Stem Cells$295,438
R01 · FY2005 · AA
TRANSCRIPTIONAL REGULATION OF CARDIOMYOCYTE DEVELOPMENT$350,816
R01 · FY2003 · HL
TRANSCRIPTIONAL REGULATION OF CARDIOMYOCYTE DEVELOPMENT$342,018
R01 · FY2002 · HL
DEGRADATION OF E12/E47 IN SMOOTH MUSCLE CELLS$115,047
K08 · FY2002 · HL
TRANSCRIPTIONAL REGULATION OF CARDIOMYOCYTE DEVELOPMENT$188,186
R01 · FY2001 · HL
TRANSCRIPTIONAL REGULATION OF CARDIOMYOCYTE DEVELOPMENT$145,579
R01 · FY2001 · HL
DEGRADATION OF E12/E47 IN SMOOTH MUSCLE CELLS$115,047
K08 · FY2001 · HL
TRANSCRIPTIONAL REGULATION OF CARDIOMYOCYTE DEVELOPMENT$325,804
R01 · FY2000 · HL
DEGRADATION OF E12/E47 IN SMOOTH MUSCLE CELLS$115,047
K08 · FY2000 · HL